Xponance Inc. boosted its position in HCA Healthcare, Inc. (NYSE:HCA - Free Report) by 12.3% in the 1st quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 39,703 shares of the company's stock after purchasing an additional 4,342 shares during the period. Xponance Inc.'s holdings in HCA Healthcare were worth $13,719,000 as of its most recent SEC filing.
A number of other large investors have also recently bought and sold shares of HCA. Norges Bank acquired a new stake in HCA Healthcare during the 4th quarter valued at $840,286,000. GAMMA Investing LLC boosted its holdings in shares of HCA Healthcare by 40,527.3% during the first quarter. GAMMA Investing LLC now owns 1,703,907 shares of the company's stock worth $5,887,850,000 after purchasing an additional 1,699,713 shares during the last quarter. Royal London Asset Management Ltd. boosted its holdings in shares of HCA Healthcare by 62.0% during the fourth quarter. Royal London Asset Management Ltd. now owns 1,500,786 shares of the company's stock worth $450,461,000 after purchasing an additional 574,239 shares during the last quarter. Barclays PLC boosted its holdings in shares of HCA Healthcare by 85.7% during the fourth quarter. Barclays PLC now owns 1,061,891 shares of the company's stock worth $318,727,000 after purchasing an additional 489,916 shares during the last quarter. Finally, Two Sigma Investments LP boosted its holdings in shares of HCA Healthcare by 12,016.0% during the fourth quarter. Two Sigma Investments LP now owns 467,437 shares of the company's stock worth $140,301,000 after purchasing an additional 463,579 shares during the last quarter. Institutional investors and hedge funds own 62.73% of the company's stock.
Analyst Ratings Changes
Several research firms have recently issued reports on HCA. Wall Street Zen upgraded HCA Healthcare from a "hold" rating to a "buy" rating in a report on Saturday, July 5th. Morgan Stanley set a $410.00 target price on HCA Healthcare and gave the stock an "equal weight" rating in a research report on Monday, June 9th. Guggenheim assumed coverage on HCA Healthcare in a research report on Wednesday, April 9th. They issued a "neutral" rating on the stock. Barclays set a $416.00 target price on HCA Healthcare and gave the stock an "overweight" rating in a research report on Monday, June 2nd. Finally, Royal Bank Of Canada reaffirmed an "outperform" rating and issued a $404.00 target price (up from $376.00) on shares of HCA Healthcare in a research report on Monday, June 23rd. Seven research analysts have rated the stock with a hold rating, eleven have given a buy rating and two have assigned a strong buy rating to the company. According to data from MarketBeat.com, the company has an average rating of "Moderate Buy" and a consensus price target of $395.71.
Read Our Latest Research Report on HCA
HCA Healthcare Stock Down 0.7%
Shares of NYSE HCA opened at $375.76 on Friday. HCA Healthcare, Inc. has a 1 year low of $289.98 and a 1 year high of $417.14. The firm has a market cap of $90.40 billion, a price-to-earnings ratio of 16.71, a PEG ratio of 1.31 and a beta of 1.47. The company has a debt-to-equity ratio of 69.07, a quick ratio of 1.06 and a current ratio of 1.19. The stock's 50-day simple moving average is $375.13 and its 200-day simple moving average is $341.72.
HCA Healthcare (NYSE:HCA - Get Free Report) last announced its earnings results on Friday, April 25th. The company reported $6.45 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $5.75 by $0.70. HCA Healthcare had a return on equity of 1,063.91% and a net margin of 8.07%. The business had revenue of $18.32 billion for the quarter, compared to analyst estimates of $18.26 billion. During the same period in the previous year, the company earned $5.36 earnings per share. The company's revenue for the quarter was up 5.7% compared to the same quarter last year. As a group, equities analysts anticipate that HCA Healthcare, Inc. will post 24.98 earnings per share for the current fiscal year.
HCA Healthcare Announces Dividend
The firm also recently disclosed a quarterly dividend, which was paid on Monday, June 30th. Shareholders of record on Monday, June 16th were issued a $0.72 dividend. This represents a $2.88 dividend on an annualized basis and a yield of 0.77%. The ex-dividend date was Monday, June 16th. HCA Healthcare's dividend payout ratio is presently 12.81%.
Insider Buying and Selling at HCA Healthcare
In other HCA Healthcare news, COO Jon M. Foster sold 15,698 shares of HCA Healthcare stock in a transaction that occurred on Tuesday, May 13th. The stock was sold at an average price of $369.32, for a total value of $5,797,585.36. Following the completion of the transaction, the chief operating officer directly owned 12,646 shares in the company, valued at $4,670,420.72. The trade was a 55.38% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is available at this link. 1.30% of the stock is currently owned by corporate insiders.
HCA Healthcare Company Profile
(
Free Report)
HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.
Featured Articles

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider HCA Healthcare, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and HCA Healthcare wasn't on the list.
While HCA Healthcare currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Market downturns give many investors pause, and for good reason. Wondering how to offset this risk? Enter your email address to learn more about using beta to protect your portfolio.
Get This Free Report